Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Eriksson

Showing results (281-290 of 1,234) with videos related to

Pageof 124
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 5, 2019
Epidemiology and control of meticillin-resistant Staphylococcus aureus in Stockholm County, Sweden, 2000 to 2016: overview of a "search-and-contain" strategyBjörn K G Eriksson, Ulla-Britt Thollström, Joanna Nederby-Öhd, et al.
Clinical Pharmacokinetics|July 9, 2003
No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitorKarin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison, et al.
European Journal of Clinical Pharmacology|July 8, 2003
Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acidGunnar Fager, Marie Cullberg, Maria Eriksson-Lepkowska, et al.
Clinical Pharmacokinetics|May 13, 2003
No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteersLinda C Johansson, Magnus Andersson, Gunnar Fager, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juiceA Miniscalco, J Lundahl, C G Regårdh, et al.
Physical Review Letters|March 5, 2009
Sawtooth-control mechanism using toroidally propagating ion-cyclotron-resonance waves in tokamaksJ P Graves, I Chapman, S Coda, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 5, 2021
Body surface area may explain sex differences in findings from the oral glucose tolerance test among subjects with normal glucose toleranceSamuel Palmu, Susanna Kuneinen, Hannu Kautiainen, et al.
Drug Design, Development and Therapy|March 10, 2022
Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy VolunteersSusanne Prothon, Magnus Aurivillius, Ulrika Tehler, et al.
The Journal of Nutrition, Health & Aging|June 28, 2005
Relationship between MNA and SF-36 in a free-living elderly population aged 70 to 75B G Eriksson, D K Dey, R M Hessler, et al.
Scandinavian Journal of Social Medicine|December 1, 1994
The Johanneberg study--a sociomedical survey in an urban elderly population. I. General presentation of the study including an analysis of non-response and identification of risk groupsO Augustsson, B G Eriksson, U Rosenhall, et al.
Pageof 124

Showing results (281-290 of 1,234) with videos related to

Sort By:
Pageof 124
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 5, 2019
Epidemiology and control of meticillin-resistant Staphylococcus aureus in Stockholm County, Sweden, 2000 to 2016: overview of a "search-and-contain" strategyBjörn K G Eriksson, Ulla-Britt Thollström, Joanna Nederby-Öhd, et al.
Clinical Pharmacokinetics|July 9, 2003
No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitorKarin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison, et al.
European Journal of Clinical Pharmacology|July 8, 2003
Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acidGunnar Fager, Marie Cullberg, Maria Eriksson-Lepkowska, et al.
Clinical Pharmacokinetics|May 13, 2003
No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteersLinda C Johansson, Magnus Andersson, Gunnar Fager, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juiceA Miniscalco, J Lundahl, C G Regårdh, et al.
Physical Review Letters|March 5, 2009
Sawtooth-control mechanism using toroidally propagating ion-cyclotron-resonance waves in tokamaksJ P Graves, I Chapman, S Coda, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 5, 2021
Body surface area may explain sex differences in findings from the oral glucose tolerance test among subjects with normal glucose toleranceSamuel Palmu, Susanna Kuneinen, Hannu Kautiainen, et al.
Drug Design, Development and Therapy|March 10, 2022
Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy VolunteersSusanne Prothon, Magnus Aurivillius, Ulrika Tehler, et al.
The Journal of Nutrition, Health & Aging|June 28, 2005
Relationship between MNA and SF-36 in a free-living elderly population aged 70 to 75B G Eriksson, D K Dey, R M Hessler, et al.
Scandinavian Journal of Social Medicine|December 1, 1994
The Johanneberg study--a sociomedical survey in an urban elderly population. I. General presentation of the study including an analysis of non-response and identification of risk groupsO Augustsson, B G Eriksson, U Rosenhall, et al.
Pageof 124